|
1
|
Wang D, Uhrin P, Mocan A, Waltenberger B,
Breuss JM, Tewari D, Mihaly-Bison J, Huminiecki Ł, Starzyński RR,
Tzvetkov NT, et al: Vascular smooth muscle cell proliferation as a
therapeutic target. Part 1: Molecular targets and pathways.
Biotechnol Adv. 36:1586–1607. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shimoda LA and Laurie SS: Vascular
remodeling in pulmonary hypertension. J Mol Med (Berl). 91:297–309.
2013. View Article : Google Scholar
|
|
3
|
Liu Y, Sun Z, Zhu J, Xiao B, Dong J and Li
X: LncRNA-TCONS_00034812 in cell proliferation and apoptosis of
pulmonary artery smooth muscle cells and its mechanism. J Cell
Physiol. 233:4801–4814. 2018. View Article : Google Scholar
|
|
4
|
Sun Z, Nie X, Sun S, Dong S, Yuan C, Li Y,
Xiao B, Jie D and Liu Y: Long non-coding RNA MEG3 downregulation
triggers human pulmonary artery smooth muscle cell proliferation
and migration via the p53 signaling pathway. Cell Physiol Biochem.
42:2569–2581. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thenappan T, Ormiston ML, Ryan JJ and
Archer SL: Pulmonary arterial hypertension: Pathogenesis and
clinical management. BMJ. 360:j54922018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Johnson J, Lakshmanan G, M B, R M V,
Kalimuthu K and Sekar D: Computational identification of MiRNA-7110
from pulmonary arterial hypertension (PAH) ESTs: A new microRNA
that links diabetes and PAH. Hypertens Res. 43:360–362. 2020.
View Article : Google Scholar
|
|
7
|
Whitaker ME, Nair V, Sinari S, Dherange
PA, Natarajan B, Trutter L, Brittain EL, Hemnes AR, Austin ED,
Patel K, et al: Diabetes mellitus associates with increased right
ventricular afterload and remodeling in pulmonary arterial
hypertension. Am J Med. 131:702.e7–702.e13. 2018. View Article : Google Scholar
|
|
8
|
Hemnes AR, Luther JM, Rhodes CJ, Burgess
JP, Carlson J, Fan R, Fessel JP, Fortune N, Gerszten RE, Halliday
SJ, et al: Human PAH is characterized by a pattern of lipid-related
insulin resistance. JCI Insight. 4:e1236112019. View Article : Google Scholar :
|
|
9
|
Zhou T, Xu X, Du M, Zhao T and Wang J: A
preclinical overview of metformin for the treatment of type 2
diabetes. Biomed Pharmacother. 106:1227–1235. 2018. View Article : Google Scholar
|
|
10
|
Li M, Li X, Zhang H and Lu Y: Molecular
mechanisms of metformin for diabetes and cancer treatment. Front
Physiol. 9:10392018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zi F, Zi H, Li Y, He J, Shi Q and Cai Z:
Metformin and cancer: An existing drug for cancer prevention and
therapy. Oncol Lett. 15:683–690. 2018.PubMed/NCBI
|
|
12
|
Ikhlas S and Ahmad M: Metformin: Insights
into its anticancer potential with special reference to AMPK
dependent and independent pathways. Life Sci. 185:53–62. 2017.
View Article : Google Scholar
|
|
13
|
Agard C, Rolli-Derkinderen M,
Dumas-de-La-Roque E, Rio M, Sagan C, Savineau JP, Loirand G and
Pacaud P: Protective role of the antidiabetic drug metformin
against chronic experimental pulmonary hypertension. Br J
Pharmacol. 158:1285–1294. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li S, Han D, Zhang Y, Xie X, Ke R, Zhu Y,
Liu L, Song Y, Yang L and Li M: Activation of AMPK prevents
monocrotaline-induced extracellular matrix remodeling of pulmonary
artery. Med Sci Monit Basic Res. 22:27–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhai C, Shi W, Feng W, Zhu Y, Wang J, Li
S, Yan X, Wang Q, Zhang Q, Chai L, et al: Activation of AMPK
prevents monocrotaline-induced pulmonary arterial hypertension by
suppression of NF-κB-mediated autophagy activation. Life Sci.
208:87–95. 2018. View Article : Google Scholar
|
|
16
|
Chaumeil J, Le Baccon P, Wutz A and Heard
E: A novel role for Xist RNA in the formation of a repressive
nuclear compartment into which genes are recruited when silenced.
Genes Dev. 20:2223–2237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ling H, Vincent K, Pichler M, Fodde R,
Berindan-Neagoe I, Slack FJ and Calin GA: Junk DNA and the long
non-coding RNA twist in cancer genetics. Oncogene. 34:5003–5011.
2015. View Article : Google Scholar :
|
|
19
|
Greco S, Gorospe M and Martelli F:
Noncoding RNA in age-related cardiovascular diseases. J Mol Cell
Cardiol. 83:142–155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vencken SF, Greene CM and McKiernan PJ:
Non-coding RNA as lung disease biomarkers. Thorax. 70:501–503.
2015. View Article : Google Scholar
|
|
21
|
Hou S, Chen D, Liu J, Chen S, Zhang X,
Zhang Y, Li M, Pan W, Zhou D, Guan L and Ge J: Profiling and
molecular mechanism analysis of long non-coding RNAs and mRNAs in
pulmonary arterial hypertension rat models. Front Pharmacol.
12:7098162021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun Z, Liu Y, Yu F, Xu Y, Yanli L and Liu
N: Long non-coding RNA and mRNA profile analysis of metformin to
reverse the pulmonary hypertension vascular remodeling induced by
monocrotaline. Biomed Pharmacother. 115:1089332019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brock M, Schuoler C, Leuenberger C,
Bühlmann C, Haider TJ, Vogel J, Ulrich S, Gassmann M, Kohler M and
Huber LC: Analysis of hypoxia-induced noncoding RNAs reveals
metastasis-associated lung adenocarcinoma transcript 1 as an
important regulator of vascular smooth muscle cell proliferation.
Exp Biol Med (Maywood). 242:487–496. 2017. View Article : Google Scholar
|
|
24
|
Zhang H, Liu Y, Yan L, Wang S, Zhang M, Ma
C, Zheng X, Chen H and Zhu D: Long noncoding RNA Hoxaas3
contributes to hypoxia-induced pulmonary artery smooth muscle cell
proliferation. Cardiovasc Res. 115:647–657. 2019. View Article : Google Scholar
|
|
25
|
Su H, Xu X, Yan C, Shi Y, Hu Y, Dong L,
Ying S, Ying K and Zhang R: LncRNA H19 promotes the proliferation
of pulmonary artery smooth muscle cells through AT1R via sponging
let-7b in monocrotaline-induced pulmonary arterial hypertension.
Respir Res. 19:2542018. View Article : Google Scholar
|
|
26
|
Zhu TT, Sun RL, Yin YL, Quan JP, Song P,
Xu J, Zhang MX and Li P: Long noncoding RNA UCA1 promotes the
proliferation of hypoxic human pulmonary artery smooth muscle
cells. Pflugers Arch. 471:347–355. 2019. View Article : Google Scholar
|
|
27
|
Zhang Y, Wang Y, Wang X, Zhang Y, Eisner
GM, Asico LD, Jose PA and Zeng C: Insulin promotes vascular smooth
muscle cell proliferation via microRNA-208-mediated downregulation
of p21. J Hypertens. 29:1560–1568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bi M, Yu H, Huang B and Tang C: Long
non-coding RNA PCAT-1 over-expression promotes proliferation and
metastasis in gastric cancer cells through regulating CDKN1A. Gene.
626:337–343. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takahashi A, Kimura F, Yamanaka A,
Takebayashi A, Kita N, Takahashi K and Murakami T: Metformin
impairs growth of endometrial cancer cells via cell cycle arrest
and concomitant autophagy and apoptosis. Cancer Cell Int.
14:532014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fornari F, Milazzo M, Chieco P, Negrini M,
Marasco E, Capranico G, Mantovani V, Marinello J, Sabbioni S,
Callegari E, et al: In hepatocellular carcinoma miR-519d is
up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21,
PTEN, AKT3 and TIMP2. J Pathol. 227:275–285. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dean A, Nilsen M, Loughlin L, Salt IP and
MacLean MR: Metformin reverses development of pulmonary
hypertension via aromatase inhibition. Hypertension. 68:446–454.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
33
|
Xu X, Gu J, Ding X, Ge G, Zang X, Ji R,
Shao M, Mao Z, Zhang Y, Zhang J, et al: LINC00978 promotes the
progression of hepatocellular carcinoma by regulating EZH2-mediated
silencing of p21 and E-cadherin expression. Cell Death Dis.
10:7522019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Song Y, Wu Y, Su X, Zhu Y, Liu L, Pan Y,
Zhu B, Yang L, Gao L and Li M: Activation of AMPK inhibits
PDGF-induced pulmonary arterial smooth muscle cells proliferation
and its potential mechanisms. Pharmacol Res. 107:117–124. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Elgendy M, Cirò M, Hosseini A, Weiszmann
J, Mazzarella L, Ferrari E, Cazzoli R, Curigliano G, DeCensi A,
Bonanni B, et al: Combination of hypoglycemia and metformin impairs
tumor metabolic plasticity and growth by modulating the
2A-GSK3β-MCL-1 axis. Cancer Cell. 35:798–815.e5. 2019. View Article : Google Scholar
|
|
36
|
Li B, Zhou P, Xu K, Chen T, Jiao J, Wei H,
Yang X, Xu W, Wan W and Xiao J: Metformin induces cell cycle
arrest, apoptosis and autophagy through ROS/JNK signaling pathway
in human osteosarcoma. Int J Biol Sci. 16:74–84. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xia C, Liu C, He Z, Cai Y and Chen J:
Metformin inhibits cervical cancer cell proliferation by modulating
PI3K/Akt-induced major histocompatibility complex class I-related
chain A gene expression. J Exp Clin Cancer Res. 39:1272020.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zahra MH, Afify SM, Hassan G, Nawara HM,
Kumon K, Seno A and Seno M: Metformin suppresses self-renewal and
stemness of cancer stem cell models derived from pluripotent stem
cells. Cell Biochem Funct. 39:896–907. 2021. View Article : Google Scholar
|
|
39
|
Liu Y, Xu Y, Zhu J, Li H, Zhang J, Yang G
and Sun Z: Metformin prevents progression of experimental pulmonary
hypertension via inhibition of autophagy and activation of
adenosine monophosphate-activated protein kinase. J Vasc Res.
56:117–128. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhuang W, Lian G, Huang B, Du A, Gong J,
Xiao G, Xu C, Wang H and Xie L: CPT1 regulates the proliferation of
pulmonary artery smooth muscle cells through the AMPK-p53-p21
pathway in pulmonary arterial hypertension. Mol Cell Biochem.
455:169–183. 2019. View Article : Google Scholar
|
|
41
|
Lee J and Kang H: Hypoxia promotes
vascular smooth muscle cell proliferation through microRNA-mediated
suppression of cyclin-dependent kinase inhibitors. Cells.
8:8022019. View Article : Google Scholar :
|
|
42
|
Kwon H, Lee JJ, Lee JH, Cho WK, Gu MJ, Lee
KJ and Ma JY: Cinnamon and its components suppress vascular smooth
muscle cell proliferation by up-regulating cyclin-dependent kinase
inhibitors. Am J Chin Med. 43:621–636. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yu JY, Lee JJ, Jung JK, Kim TJ, Yoo HS,
Yun YP and Lee JC: JY0691, a newly synthesized obovatol derivative,
inhibits cell cycle progression of rat aortic smooth muscle cells
through up-regulation of p21(cip1). Eur J Pharmacol. 624:23–30.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Poon RY, Jiang W, Toyoshima H and Hunter
T: Cyclin-dependent kinases are inactivated by a combination of p21
and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage. J
Biol Chem. 271:13283–13291. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Perros F, Montani D, Dorfmüller P,
Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E,
Mussot S, Mercier O, et al: Platelet-derived growth factor
expression and function in idiopathic pulmonary arterial
hypertension. Am J Respir Crit Care Med. 178:81–88. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jandl K, Thekkekara Puthenparampil H,
Marsh LM, Hoffmann J, Wilhelm J, Veith C, Sinn K, Klepetko W,
Olschewski H, Olschewski A, et al: Long non-coding RNAs influence
the transcriptome in pulmonary arterial hypertension: The role of
PAXIP1-AS1. J Pathol. 247:357–370. 2019. View Article : Google Scholar :
|
